It is critical for physicians to be confident and comfortable in diagnosing and managing knee osteoarthritis. Incannex announces the first dosing in a phase 2 study of a novel drug combination comprising HCQ and CBD to treat RA. Artificial intelligence can potentially detect rheumatic heart disease with the same level of accuracy as a cardiologist. Mithu Maheswaranathan, MD, spoke about challenges, treatments, and trends in rheumatology, as well as upcoming advancements. A study aimed to create a benefit-versus-harm shared decision-making tool for hydroxychloroquine for patients with SLE. Having multiple risk factors for cardiovascular disease may increase the risk of rheumatoid arthritis treatment failure. Recent safety data significantly impacted prescribing practices for advanced RA therapies among physicians treating veterans. For adults with lupus nephritis, this specific treatment combination improves total remission rate better than others. Bimekizumab demonstrated sustained efficacy for the treatment of active axial spondyloarthritis through 52 weeks. A study provided a unique characterization of a rare: large-vessel involvement from ANCA-associated vasculitis. A study sought to identify variables distinguishing inflammatory from noninflammatory arthritis in a large cohort. Abatacept improved outcomes for rheumatoid arthritis refractory to methotrexate or TNFi versus rituximab or tocilizumab. Ultra-low dose rituximab significantly reduced the rate of infections versus the standard low dosage in rheumatoid arthritis. Individuals with systemic lupus erythematosus face a substantial economic burden in the first 12 months following treatment. Researchers examined changes in objective measures of cardiorespiratory function and patient-reported outcomes in lupus. A study sought to characterize racial differences in lupus clinical manifestations. The American College of Rheumatology has released new recommendations for the management of rheumatoid arthritis. A study reported an increased psychiatric morbidity burden in patients with juvenile idiopathic arthritis. Patients with rheumatoid arthritis with lower hemoglobin levels may be more likely to have increased progression over time. Researchers established tranexamic acid was safe and effective in patients with rheumatoid arthritis following TKA.